Nova EYE Medical Ltd - Asset Resilience Ratio

Latest as of December 2025: 11.08%

Nova EYE Medical Ltd (EYE) has an Asset Resilience Ratio of 11.08% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Nova EYE Medical Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$2.62 Million

≈ $1.86 Million USD Cash + Short-term Investments

Total Assets

AU$23.67 Million

≈ $16.75 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Nova EYE Medical Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EYE asset base.

Liquid Assets Composition Over Time

This chart breaks down Nova EYE Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read EYE total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$2.62 Million	11.08%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$2.62 Million	11.08%

Asset Resilience Insights

Moderate Liquidity: Nova EYE Medical Ltd has 11.08% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Nova EYE Medical Ltd Industry Peers by Asset Resilience Ratio

Compare Nova EYE Medical Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%

Annual Asset Resilience Ratio for Nova EYE Medical Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Nova EYE Medical Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	19.07%	AU$5.05 Million ≈ $3.58 Million	AU$26.50 Million ≈ $18.75 Million	-1.51pp
2024-06-30	20.58%	AU$6.15 Million ≈ $4.35 Million	AU$29.88 Million ≈ $21.14 Million	-3.85pp
2023-06-30	24.44%	AU$7.42 Million ≈ $5.25 Million	AU$30.36 Million ≈ $21.48 Million	+2.60pp
2022-06-30	21.84%	AU$8.00 Million ≈ $5.66 Million	AU$36.62 Million ≈ $25.91 Million	-20.55pp
2021-06-30	42.39%	AU$17.80 Million ≈ $12.60 Million	AU$41.99 Million ≈ $29.71 Million	-39.54pp
2020-06-30	81.93%	AU$95.65 Million ≈ $67.68 Million	AU$116.74 Million ≈ $82.60 Million	+66.54pp
2019-06-30	15.39%	AU$15.37 Million ≈ $10.88 Million	AU$99.89 Million ≈ $70.68 Million	-6.91pp
2018-06-30	22.29%	AU$23.07 Million ≈ $16.32 Million	AU$103.47 Million ≈ $73.21 Million	+11.61pp
2017-06-30	10.68%	AU$9.24 Million ≈ $6.54 Million	AU$86.54 Million ≈ $61.23 Million	+10.30pp
2008-06-30	0.38%	AU$275.00K ≈ $194.58K	AU$71.94 Million ≈ $50.90 Million	+0.12pp
2007-06-30	0.26%	AU$167.00K ≈ $118.16K	AU$63.69 Million ≈ $45.06 Million	+0.16pp
2006-06-30	0.10%	AU$46.00K ≈ $32.55K	AU$46.48 Million ≈ $32.88 Million	-42.45pp
2001-06-30	42.54%	AU$487.42K ≈ $344.88K	AU$1.15 Million ≈ $810.63K	--

pp = percentage points

About Nova EYE Medical Ltd

AU:EYE Australia Medical Devices

Market Cap

$26.20 Million

AU$37.03 Million AUD

Market Cap Rank

#24309 Global

#969 in Australia

Share Price

AU$0.13

Change (1 day)

-3.70%

52-Week Range

AU$0.10 - AU$0.20

All Time High

AU$0.46